Overview
Glycol salicylate, also known as 2-hydroxyethyl salicylate, is a benzoate ester formed from the condensation of the carboxy group of salicylic acid with one of the hydroxy groups of ethylene glycol. It is found as an active ingredient and topical analgesic in patches used to provide relief for mild to moderate muscle and joint pain . This drug belongs to the salicylate group of drugs, which are used as analgesic agents for the treatment of mild to moderate pain . Glycol salicylate (GS), composed of salicylic acid (SA) and ethylene glycol, is a non-steroidal anti-inflammatory drug . This ingredient is an important component of many topical creams and sprays for the relief of aches, pains, and stiffness of the muscles, joints, and tendons .
Indication
This drug is only recommended for topical usages for the relief of muscular and rheumatic pain in human and animals .
Associated Conditions
- Back Pain Lower Back
- Chilblains
- Contusions
- Joint Pain
- Myalgia
- Pain caused by Fracture Bone
- Sprains
- Stiff Shoulder
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
PANADOL PAIN RELIEF PATCH | N/A | N/A | N/A | 11/3/2007 | |
BENTPLA GEL | N/A | N/A | N/A | 1/28/2010 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
JUPITER PAIN PATCH | jupiter consumer products ltd. | 02275198 | Patch - Topical | 1.0 % | N/A |
MIDALGAN | welcker-lyster ltd., division of technilab inc. | 00234575 | Ointment - Topical | 10 G / 100 G | 12/31/1948 |
TOKUHON MEDICATED PLASTER | eastland drug co. ltd. | 02178478 | Plaster - Topical | 1.62 % | 2/27/1998 |
ULTRAPLAST ANALGESIC SPRAY | wallace, cameron and company ltd. | 00257036 | Aerosol - Topical | 4.8 % | 12/31/1985 |
SALONPAS - PLS TOP | 02179520 | Plaster - Topical | .9 % | 8/3/1995 | |
SALONPAS GEL-PATCH | 02238054 | Plaster - Topical | 1.25 G / 100 G | 2/1/2002 | |
NEW AMMELTZ | classical remedia ltd | 02322714 | Liquid - Topical | 25 MG / ML | N/A |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.